1-hydroxy-3-amino-2-pyrrolidone and ketamine

1-hydroxy-3-amino-2-pyrrolidone has been researched along with ketamine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Millan, MJ1
Harris, KM; Miller, RJ; Reynolds, IJ1
Adam, F; Chauvin, M; Gairard, AC; Guirimand, F; Le Bars, D1

Other Studies

3 other study(ies) available for 1-hydroxy-3-amino-2-pyrrolidone and ketamine

ArticleYear
Antagonists at the NMDA recognition site and blockers of the associated ion channel induce spontaneous tail-flicks in the rat.
    European journal of pharmacology, 1991, Oct-15, Volume: 203, Issue:2

    Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Ion Channels; Ketamine; Male; N-Methylaspartate; Organophosphorus Compounds; Phencyclidine; Pipecolic Acids; Piperazines; Piperidines; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate

1991
NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
    European journal of pharmacology, 1989, Mar-07, Volume: 172, Issue:1

    Topics: Animals; Anticonvulsants; Aspartic Acid; Brain; Calcium; Desipramine; Dibenzocycloheptenes; Dizocilpine Maleate; gamma-Aminobutyric Acid; Ketamine; Kynurenine; Membranes; N-Methylaspartate; Piperazines; Pyrrolidinones; Radioligand Assay; Rats; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Strychnine

1989
Effects of sufentanil and NMDA antagonists on a C-fibre reflex in the rat.
    British journal of pharmacology, 2001, Volume: 133, Issue:7

    Topics: Analgesics, Opioid; Animals; Brain; Dose-Response Relationship, Drug; Electric Stimulation; Excitatory Amino Acid Antagonists; Injections, Intravenous; Ketamine; Male; Nerve Fibers; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex; Sufentanil

2001